The European Association for Cancer Research
Advancing cancer research - from basic research to prevention, treatment and care
News
Positions at the Cancer Epigenetics and Biology Program (PEBC), Barcelona
1 Junior Group Leader (Includes funding for reagents and personnel)
1 Research Associate
3 Postdoctoral Researchers
3 PhD Students
3 Technicians (Including a confocal specialist)
1 Scientific Management Officer
The Catalan Institute of Oncology (Institut Català d'Oncologia, ICO) is a nonprofitable public company, created in March 1995 and member of the Servei Català de la Salut (Catalan Health Service). The Institute is a centre of integral oncology assistance, which, according to international tendency, integrates in only one organization all the elements and the efforts to fight effectively and efficiently against cancer. The Institute is a centre highly specialized and advanced in oncology which offers in a coordinated way: diagnostic, treatment, prevention, training and research. In accordance with the comprehensive cancer centre model, ICO is committed to the physical proximity of research to clinical activity in order to ensure better results in terms of knowledge transfer. Hence considerable effort has been made in recent years to foster research. According to this, ICO had three research programs: Epidemiology and prevention of cancer, Translational research and Clinical research.
It is a great pleasure to announce the launching in 2008 of a fourth research program devoted to Basic research, the "Cancer Epigenetics and Biology Program" (PEBC) headed by Manel Esteller, M.D., Ph.D. The research program is supported by the Departament de Sanitat de la Generalitat de Catalunya, Ministerio de Sanidad y Consumo, Ministerio de Ciencia e Innovacion and the Catalan Institution for Research and Advanced Studies (ICREA). Current research projects developed at the PEBC include, but are not restricted to, cancer epigenetics, chromatin and stem cell biology, aging, cell cycle and transformation, imprinting and the identification of cancer genes. Representative high impact publications from the Principal Investigators of PEBC include Nat Genet 37:391-400, 2005; Nat Cell Biol 7:930-2, 2005; Nat Genet 37:1063-71, 2005; Nat Genet 38:566-9, 2006; Cell 125:719-32, 2006; Genes Dev 20:1256-61, 2006; Nat Rev Genet 2007; Nat Genet 39: 279-80, 2007; Nature 450: 440-4, 2007; N Engl J Med 358:1148-59, 2008.
We encourage applications from highly motivated candidates with excellent qualifications in biomedical and life sciences, molecular and cellular biology or biochemistry for the following positions:
1 Junior Group Leader (Includes funding for reagents and personnel)
1 Research Associate
3 Postdoctoral Researchers
3 PhD Students
3 Technicians (Including a confocal specialist)
1 Scientific Management Officer
The place of employment and work is the Cancer Epigenetics and Biology Program of the Catalan Institute of Oncology, located at the Parc Sanitari Duran i Reynals, Av. Gran Via s/n Km 2,7 08907 L'Hospitalet de Llobregat , Barcelona, Catalonia, Spain. Applicants are required to submit a curriculum vitae in English, a copy of the degree certificate and a letter of interest to Ms. Anna Verges (averges@iconcologia.net) or Dr. Manel Esteller (mesteller@iconcologia.net). Any potential applicant is invited to apply irrespective of age, sex, race, religion or ethnic background. We encourage unsolicited applications from excellent applicants at all times.
For further information, please visit http://www.pebc.cat
PEBC Cancer Epigenetics and Biology Program Programa d’Epigenètica i Biologia del Càncer Programa de Epigenética y Biología del Cáncer
Members' Log in
Latest News
Six Countries qualify for 'National Network' representative seats on the new EACR Council
Newsletter 2008
The 40th Anniversary newsletter is now available online
The Newsletter is available to download
in full or in sections on the special Anniversary Newsletter Page by following
this link - click here.
Keep contact details up to date to receive regular EACR news by e-mail and air-mail
Members' Items
EACR Council
Nominations invited for seats on the EACR Council
ECCO eLEARNING programme
Click here to view the document >
Survey 2008: feedback to members
Click here to login and read survey >
Jobs and Study Opportunities
PhD students and Postdoc scientists to study autophagy in cancer, Università “A. Avogadro”, Novara, Italy
Enthusiastic and highly motivated PhD students (3 positions) and postdoctoral scientists (3 positions) are sought to work on the role of autophagy in cancer progression and chemoresistance at the Department of Medical Sciences, University Amedeo Avogadro in Novara, Italy.
Grant Application Announcement
World Cancer Research Fund (WCRF) International is now inviting applications for grants worldwide to fund research into the effects of food, nutrition and physical activity on cancer. WCRF International may also co-fund breast cancer project grants with Breast Cancer Campaign.
Postdoctoral positions to work on SUMO and Ubiquitin
MRC funded 4 year posts (X2)
SCILLS funded 4 year posts (X2)
BBSRC funded 2.5 year post
Informatics Data Manager 4 year post
Enthusiastic and highly motivated postdoctoral scientists are sought to work on the role of ubiquitin and SUMO in pathways contributing to disease in humans. The successful applicants will join a team of researchers tackling these problems in the laboratory of Ron Hay. This is a well resourced laboratory in the College of Life Sciences which has excellent facilities for high-resolution mass spectrometry, X-ray Crystallography, light and electron microscopy, flow cytometry and whole genome siRNA screening.
Positions at the Cancer Epigenetics and Biology Program (PEBC), Barcelona
1 Junior Group Leader (Includes funding for reagents and personnel)
1 Research Associate
3 Postdoctoral Researchers
3 PhD Students
3 Technicians (Including a confocal specialist)
1 Scientific Management Officer
The Catalan Institute of Oncology (Institut Català d'Oncologia, ICO) is a nonprofitable public company, created in March 1995 and member of the Servei Català de la Salut (Catalan Health Service). The Institute is a centre of integral oncology assistance, which, according to international tendency, integrates in only one organization all the elements and the efforts to fight effectively and efficiently against cancer.
University of Nice, CNRS, Inserm
Five Group Leaders
CANCER RESEARCH CENTER
The Inserm Federative Institute (IFR50, www.ifr50.fr/) and the CNRS Research Institute of Developmental Biology & Cancer (UMR6543, www.unice.fr/isdbc/), both affiliated to the University of Nice are preparing the emergence of a Cancer Research Center regrouping world class research teams in the field of Cancer Biology/Stem Cells and in close cooperation with the University Hospital and Cancer Center Antoine Lacassagne of Nice.
Postdoc for epigenetic analyses in breast carcinogenesis, Heidelberg University & DKFZ
Division of Toxicology and Cancer Risk Factors. The project will involve the establishment of high throughput methods to quantify methylation levels of DNA using MassARRAY technology. In addition, molecular-biological techniques will be used for the functional analysis of identified genes.
University of Duisburg-Essen, Germany
1 Post Doc and 3 PhD-positions in Experimental Oncology
Institute for Cell Biology (Tumour Research), Department of Molecular Cell
Biology
Postdoctoral position available
The package includes a competitive salary 36.000 euros/year, managerial and scientific training and a number of benefits.
IFOM-IEO Campus, Milan, Italy
For further information >Post-Doctoral Position, The Immunotherapy & Gene Therapy Unit
The Immunotherapy & Gene Therapy Unit seeks a candidate with experience in immunology to study regulatory T cells expansion, conversion and inactivation in tumor bearers using a variety of mixed bone marrow chimeras as well as gene shut down in bone marrow donors.